COMP vs KRG

Compass, Inc. exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, placing it in the 'Weak' health category. While the company maintains strong top-line revenue growth of 23.10% and a low Price/Sales ratio of 0.84, these are offset by negative profit margins, a negative ROE of -9.79%, and a concerning liquidity position with a current ratio of 0.86. There is a stark disconnect between the bullish analyst target price of $13.25 and the internal reality of consistent earnings misses (0/4 beats in the last year) and aggressive insider selling by the CFO and General Counsel.

KRG presents a stable but contradictory profile, anchored by a Piotroski F-Score of 4/9 indicating stable financial health. While the current price of $26.15 sits comfortably below the growth-based intrinsic value of $40.42, it trades at a premium to the Graham Number of $21.29. The most concerning metric is the spike in Forward P/E to 47.98, suggesting a significant projected decline in earnings. Despite strong historical price performance and a healthy Debt/Equity ratio, bearish technical trends and insider selling signal short-term caution.